Over the years, the incidence of various chronic diseases, such as diabetes, multiple sclerosis and rheumatoid arthritis, have increased at significant rates.
The global autoinjectors market size is estimated to be worth USD 96.2 billion in 2025 and is projected to reach USD 176 billion by the year 2035, growing at a CAGR of 6.2% during the forecast period, till 2035.
In pursuit of obtaining a competitive edge, companies are presently engaged in integrating advanced features in their autoinjectors and augmenting their product portfolio offerings
In order to determine the relative competitiveness of autoinjectors, we focused on several relevant parameters, such as manufacturer strength (in terms of experience and company size), product portfolio strength (in terms of the stage of development, type of primary drug container, requirement of needle, volume of container, type of dose delivered, type of actuation mechanism, type of feedback mechanism, number of target indication and number of molecule delivered), and number of end-users. Syrina AR, Syrina AS, Syrina S and Viscala (manufactured by Recipharm) emerged as the most competent disposable autoinjectors, in terms of product portfolio strength. These autoinjectors are compatible with both cartridges and syringes (with needle safety features). Notably, these devices use VapourSoft technology (involving liquefied gas) to deliver high viscosity drugs with ease (when compared to conventional spring-based autoinjectors).
Various firms in the autoinjectors domain are increasingly entering into collaborations with local and international players to expand their capabilities, leverage complementary expertise and access new markets. The rising interest in the autoinjectors domain is reflected in the wide array of partnerships established between various stakeholders in the recent past. The maximum number of partnerships in this domain were signed in the year 2022 and 2019. Notably, product development agreements emerged as the most prominent type of partnership model adopted by the stakeholders in this domain; this is followed by product licensing agreements and acquisitions. Further, majority of the partnerships were inked between players based in the same region (intracontinental deals). It is worth highlighting that in the current scenario, companies headquartered in Europe are actively investing in consolidating their indigenous presence by seeking collaborations in this domain.
Research Methodology
Our analysts have performed an accurate examination of the various aspects of the global market leveraging avant-garde primary and secondary sources of data collection. The report has gathered the necessary data and information from several reliable sources. Additionally, the report offers many strategic recommendations for companies involved in this ever-growing business sector to help them attain a competitive edge in the Autoinjectors Market.
Thank you for reading our report. Kindly get in touch with us to know more about the report or to receive a customized copy of it. Our team will ensure the report is tailored according to your needs.
To view more details on this report, click on the link
https://www.rootsanalysis.com/reports/autoinjectors-market/293.html
About Roots Analysis
Roots Analysis is a global leader in the pharma / biotech market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights.
We specialise in analysing areas which have lacked quality research so far or require more focused understanding within the broader industry. All our reports are structured in a way to enable the reader develop a thorough perspective on the given subject. Apart from writing reports on identified areas, we also provide bespoke research / consulting services dedicated to serve our clients in the best possible way.
The research efforts are driven by a global team. The leadership team brings a wealth of experience within the sector. Their collective experience in pharmaceutical / affiliated domains allows us to tackle various areas of research in a structured way. We also regularly leverage our global network of experts who hold senior leadership positions in reputed firms and organisations worldwide.
Contact:
Roots Analysis
+1 (415) 800 3415
Comments